Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention
D. Gareth Evans(Manchester Academic Health Science Centre), Anthony Howell(Breast Cancer Care), Jack Cuzick(Queen Mary University of London), Sarah Dawe(Wythenshawe Hospital), Mary Wilson(St Mary's Hospital), John Ainsworth(University of Manchester), Michelle Harvie(Manchester Academic Health Science Centre), Paula Stavrinos(Breast Cancer Research Foundation), Adam R. Brentnall(Queen Mary University of London), Louise S. Donnelly(Breast Cancer Research Foundation), Iain Buchan(University of Liverpool), Susan Astley(University of Manchester), Jamie C. Sergeant(Manchester Academic Health Science Centre)
Cited by 54
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k